Medrio releases tablet-based eConsent app

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/westend61)
(Image: Getty/westend61)

Related tags: eConsent, Application software, CRO, Patient recruitment, Patient centricity

Medrio’s FDA-compliant tablet-based electronic-consent application for clinical trial participants looks to improve comprehension with graphics and videos.

The eClinical technology company released Medrio eConsent to provide clients with an electronic-consent (eConsent) application to accelerate clinical trial processes. The product uses the cloud to enable sponsors and contract research organizations (CROs) to access consent forms instantly.

Medrio eConsent incorporates graphics, videos, quiz modules, and frequently asked questions (FAQ) documents in an aim to increase patient comprehension during informed consent. Patient’s personally identifiable information (PII) will be protected through encryption measures.

After two rounds of Beta testing, in which patients interacted with the app in test environments, the product is set for the market, according to the company..

Beta testing participant and clinical research programmer at the University of California, San Francisco stated in a press release, “An automated process of document versioning and centralized record storage also enables us to ensure that our consenting process is accurate and compliant with both the study protocol and Institutional Review Board (IRB) guidelines.”

The release comes on the heels of the FDA’s guidance on the use of eConsent, and this year’s General Data Protection Regulation (GDPR), which requires the industry to provide a thorough consent process that is ‘comprehensible to the layperson.’

Related news

Show more

Related products

show more

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Products

View more

Webinars